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ta.2013.0Abstract Objective: This study sought to determine causative microorganisms of chronic suppu-
rative otitis media (CSOM) and to estimate their susceptibility to antibiotic agents.
Materials and methods: One hundred sixty-four (164) patients with unilateral or bilateral active
chronic suppurative otitis media were prospectively studied. They had chronic ear discharge and
had not received any antibiotics for the previous 5 days. Swabs were taken from all patients, and
sent to the Microbiology Department for processing. The specimens were cultured and the isolates
were identiﬁed using standard microbiological techniques. The antibiotic susceptibilities of the iso-
lates were determined with standard antibiotic discs using the Kirby–bauer disc diffusion method.
Results: This study analyzes the causal organisms and their sensitivity to various antibiotics. The
major organisms isolated were Methicillin sensitive Staphylococcus aureus [MSSA] (45.1%) followed
byPseudomonas aeruginosa (19.5%). The sensitivity of S. aureus (MSSA) was 79.7% to ciproﬂoxacin,
69% to cotrimoxazole, and 82.5% to gentamicin whereas the sensitivity ofP. aeruginosawas 100% to
ceftazidime, 84.4% to ciproﬂoxacin, 90.6% to gentamicin, and 78.1% to Piperacillin. Majority of the
isolates of P. aeruginosa were completely resistant to polymixin B (71.9%) whereas 50% of S. aureus
(MSSA) showed resistance to Ampicillin. All Methicillin resistant S. aureus (MRSA) isolates showed
100% resistance to Ampicillin, Augmentin and cephalothin. Among the available topical antibiotic
preparations for use in the ear, we found gentamicin and ciproﬂoxacin as the best choices.
Conclusion: The study ofmicrobial pattern and their antibiotic sensitivity determines the prevalent
bacterial organisms causingCSOM in the local area to start empirical treatment of otitis media and its
complications for a successful outcome, and thus to prevent the emergence of resistant strains.
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6.0011. Introduction
Chronic suppurative otitis media (CSOM) is deﬁned as a
chronic inﬂammation of the middle ear and mastoid cavity,
which presents with recurrent ear discharges or otorrhoea
through a tympanic membrane perforation. The disease
usually begins in childhood1,2 as a tympanic membranegyptian Society of Ear, Nose, Throat and Allied Sciences.
Table 1 Age distribution of the patients.
Age group (in years) 0–12 13–20 21–30 31–40 41–50 >50 Total
Number of patients 05 41 52 09 35 22 164
192 S. Ahmadperforation due to an acute infection of the middle ear, known
as acute otitis media (AOM), or as a sequel of less severe forms
of otitis media (e.g. secretary OM).3–5 The infection may occur
during the ﬁrst 6 years of a child’s life, with a peak around
2 years.6 The point in time when AOM becomes CSOM is still
controversial. Generally, patients with tympanic perforations
which continue to discharge mucoid material for periods from
6 weeks7 to 3 months, despite medical treatment, are recog-
nized as CSOM cases. Chronic suppurative otitis media
(CSOM) is a commonly encountered infection of the middle
ear all over the world. In 1990, about 28,000 deaths all over
the world and largely among developing countries were due
to otitis media.8,9 Mortality and disabilities due to otitis media
are primarily related to the complications of CSOM,10 partic-
ularly brain abscess.11 Population-based estimates in develop-
ing countries range from 0.24% in Thailand to 1.8% in Africa.
In South Korea, 10.4% of CSOM had complications.12
Chronic suppurative otitis media (CSOM) has assumed world-
wide importance. For instance, the United States government
spends over 2 billion dollars yearly to treat acute and chronic ear
infections.13 In the developing countries, it has continued to consti-
tute a heavy disease burden, with the prevalence of chronic ear
infections being up to 72 cases per 1000 inhabitants.14
So untreated cases of CSOM can result in a broad range of
complications. These may be related to the spread of bacteria
to structures adjacent to the ear or to local damage in the mid-
dle ear itself. Such complications range from persistent otor-
rhoea, mastoiditis, labyrinthitis, facial nerve paralysis to
more serious intracranial abscesses or thromboses.15–17 So
the knowledge of the local pattern of infection is essential to
enable efﬁcacious treatment of this disorder. The goal of the
management is to achieve a safe, dry ear, eradicate disease
and improve hearing.
The main aim of this study was to determine the microbial
proﬁle (aerobic and anaerobic) and the antibiograms of active
CSOM patients among Saudi population. CSOM is a very
common problem in Saudi Arabia and is seen mostly in pop-
ulations from far ﬂung areas.
2. Methods
This study was conducted on Outpatient basis in the Depart-
ment of Ear, Nose and Throat (ENT) over a period of one
and a half (11/2) years = from September, 2011 to February,
2013. In this prospective study, a total of one hundred sixty-
four (164) patients were involved. All our patients had perfo-
rated tympanic membranes with active purulent discharge. De-
tailed clinical history regarding age, sex, duration of discharge
and antibiotic treatment was taken. Only patients who had not
received antibiotic therapy (topical or systemic) for the previ-
ous 5 days were included in the study. Single use Mini-tip Cul-
ture swabs were used to harvest the middle ear microﬂora
through the tympanic membrane perforation. Much care was
taken to avoid surface contamination and the swabs were
transported to the microbiology department of the hospital
for culture and sensitivity testing. A total of 164 swabs were
taken from 164 patients, processed aerobically and anaerobi-
cally for the isolation of aerobic and anaerobic bacteria, using
standard microbiological procedures. All organisms isolated
were identiﬁed according to standard microbiological
methods.Antibiotic susceptibility testing was carried out using the
Kirby–Bauer disc diffusion technique on Muller–Hinton agar
and commercial antibiotic discs (Oxoid, United Kingdom)
were used for antimicrobial testing.18 The antibiotic discs used
were: Penicillin G (10U), Ampicillin (10 lg), Augmentin
(30 lg), Trimethoprim-Sulphamethoxazole (1.25/23.75 lg),
Cephalothin (30 lg), Polymixin B (300 U), Ceftazidime
(30 lg), Piperacillin (100 lg), Chloramphenicol (30 lg), Cipro-
ﬂoxacin (5 lg), Amikacin (30 lg), Gentamicin (10 lg), Neomy-
cin (30 lg) and Bacitracin (10 U).
Apart from the standard antibiotics, testing was also done
speciﬁcally for Gentamicin, Neomycin, Chloramphenicol and
Bacitracin which are available locally as topical antibiotic ear-
drops. The antibiotic disc impregnated culture plates were
incubated at 37 C overnight. The diameter of the zone of inhi-
bition was measured and recorded as resistant or susceptible
according to the National Committee for Clinical Laboratory
Standards (NCCLS) interpretative criteria.19
3. Results
The mean age of patients was 25 years, with the range being
between 20–47 years (Table 1). From the 164 patients enrolled
in the study, there were 148 (90.2%) isolates. Ninety-four (94)
patients (63.5%) had a single organism isolated from the mid-
dle ear culture, while the remaining 54 patients had two or
more organisms isolated. There were only sixteen patients
(9.8%) who had a sterile culture with no bacteria isolated (Ta-
ble 2). The most common causal organisms isolated were
Methicillin sensitive Staphylococcus aureus [MSSA] (45.1%),
followed by Pseudomonas aeruginosa (19.5%), Methicillin
Resistant S. aureus (MRSA), Coagulase negative Staphylococ-
cus, Proteus mirabilis and Escherichia coli (Table 2). The anti-
microbial sensitivities of the organisms were tested and the
results for the six most common organisms are shown (Ta-
ble 3). Of the four antibiotics that are available commonly as
topical eardrops, gentamicin has the highest susceptibility rate
(88.3%) for all the isolates tested, followed by chlorampheni-
col (72.4%). Neomycin showed 74.3% sensitivity against
Gram negative bacteria while isolates of MSSA, MRSA and
Coagulase negative Staphylococcus showed 78.8% susceptibil-
ity to Bacitracin.
4. Discussion
Chronic suppurative otitis media and its complications are
among the most common conditions seen by otologists and
general practitioners. Chronic suppurative otitis media is a
persistent inﬂammation of the middle ear or mastoid cavity,
and is characterized by recurrent or persistent ear discharge
through a perforation of the tympanic membrane.20 Due to
the perforated tympanic membrane, bacteria can gain entry
into the middle ear via the external ear canal. Infection of
the middle ear mucosa subsequently results in ear discharge.
Chronic suppurative otitis media is a common and potentially
Table 2 Microorganisms isolated in positive cultures.
Organism Number Percentage (%)
Gram Positive
Staph. aureus (MSSA) 74 45.1
Staph. aureus (MRSA) 19 11.6
Coagulase ve Staph. 9 5.5
Gram Negative
Pseudomonas aeruginosa 32 19.5
Proteus miribilis 6 3.7
E. coli 4 2.4
Citrobacter Spp. 3 1.8
Anaerobe
Bacteroids spp. 01 0.6
No growth 16 9.8
Total 164 100
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the most common infecting organisms are often resistant to
many antibiotics.21 Untreated cases of CSOM can result in a
broad range of complications. These may be related to the
spread of bacteria to structures adjacent to the ear or to local
damage in the middle ear itself. Such complications range from
persistent otorrhoea, mastoiditis, labyrinthitis, facial nerve
paralysis to more serious intracranial abscesses or thrombo-
ses.15,16 While the incidence of such complications is low, they
need to be borne in mind when faced by a patient with active
CSOM.
Treatment hence needs to be instituted early and effectively
to avoid such complications. The treatment of this condition
can be medical; with therapy directed at eradicating patho-
genic aerobic and anaerobic organisms.22 Those cases that
are resistant to medical treatment might need surgical
intervention.
The mainstay of treatment for uncomplicated CSOM is
twofold: meticulous aural toilet (with suction/mopping up of
ear debris and discharge) and instillation of a topical and sys-
temic antimicrobial agent. The therapeutic use of antibiotics is
usually started empirically prior to results of microbiological
culture. Selection of any antibiotic is inﬂuenced by its efﬁcacy,
resistance of bacteria, safety, risk of toxicity and cost. Knowl-
edge of the local microorganism pattern and their antibioticTable 3 Antimicrobial susceptibility pattern of major organisms ca
Percent of resistant isolates against
Organism P AMP COT AMC CTN P
Gram positive bacteria
S. aureus (MSSA) 52.7 50.0 31.0 35.1 50.0 N
S. aureus (MRSA) 100 100 31.6 100 100 N
Coag. ve Staph. 55.5 44.4 55.5 44.4 55.5 N
Gram negative bacteria
Pseudomonas aeruginosa NT NT NT NT NT 7
Proteus mirabilis NT 33.3 33.3 16.6 NT 5
Escherichia coli NT 25.0 25.0 25.0 100 5
P = Penicillin, AMP= Ampicillin, COT= Cotrimoxazole, AMC=Au
dime, PIP = Piperacillin, C = Chloramphenicol, CIP = Ciproﬂoxa
BAC= Bacitracin, NT =Not tested.sensitivity is then essential to allow for effective and cost-sav-
ing treatment. Microbiology cultures yield many, frequently
multiple, organisms and these vary depending on climate, pa-
tient population and whether antibiotics have or have not been
recently used. Several studies have reported different organ-
isms in different proportions.17 Our study showed that active
CSOM infection in the Saudi population is mainly due to S.
aureus, P. aeruginosa followed by P. mirabilis. Similar ﬁndings
have been reported by Gehanno.21 S. aureus (MSSA) was the
commonest organism isolated, although various such studies
in different countries have shown P. aeruginosa to be more
common.16 Our study showed the predominance of S. aureus
followed by P. aeruginosa which is in agreement with oth-
ers.21,23 This ﬁnding is in agreement with the pattern of CSOM
infection within the tropical region. The antibiotic susceptibil-
ity pattern of MSSA showed that 82% were sensitive to genta-
micin, 80% were sensitive to ciproﬂoxacin and 79.7% to
Bacitracin. Antimicrobial sensitivity of P. aeruginosa in our
study revealed that ceftazidime was sensitive in 100%, Genta-
micin was sensitive in 91%, Ciproﬂoxacin was sensitive in
85% and 78% were sensitive to Piperacillin. Previously
amoxicillin/ampicillin was used frequently than quinolones
for acute and chronic middle ear infections in our set up.
But the present study has clearly shown a changing behaviour
of microorganisms, showing more sensitivity to quinolones,
cephalosporins and gentamicin. Also the clinicians used to
avoid the use of quinolones due to their adverse effects on car-
tilage in growing children after their prolonged usage, however
it has been documented that quinolones can be used if required
in children without any apprehensions.24,25 So the use of cipro-
ﬂoxacin has been found superior both empirically and topi-
cally. Among the most commonly available topical antibiotic
solutions gentamicin has shown promising results after cipro-
ﬂoxacin. Added advantage of ciproﬂoxacin ear drops over gen-
tamicin is not being ototoxic.26 There remains, however a
controversy over the question of ototoxicity with the topical
usage of aminoglycoside (gentamicin) while the systemic usage
of aminoglycoside has been known to have a deleterious effect
on the inner ear. The fact that the disease process in CSOM it-
self causes a sensorineural hearing loss26 has led many to con-
clude the beneﬁts derived from the usage of topical
aminoglycosides in the treatment of CSOM and the
prevention of attendant complication far outweigh theusing CSOM.
B CAZ PIP C CIP AK GM NEO BAC
T NT NT 20.3 20.3 21.6 17.5 NT 20.3
T NT NT 31.6 36.8 21.0 15.8 NT 21.0
T NT NT 33.3 22.2 22.2 11.1 NT 22.2
1.9 0 21.9 21.9 15.6 21.9 9.4 18.7 NT
0.0 33.3 16.6 33.3 16.6 33.3 16.6 33.3 NT
0.0 25.5 25.0 25.0 0 25.0 0 25.0 NT
gmentin, CTN= Cephalothin, PB = Polymixin B, CAZ= Ceftazi-
cin, AK= Amikacin, GM=Gentamicin, NEO=Neomycin,
194 S. Ahmadototoxic side-effects which may potentially occur. Keeping in
view the high prevalence of S. aureus and P. aeruginosa in
our set up and their high susceptibility to quinolones (cipro-
ﬂoxacin) and cephalosporins (ceftazidime), ciproﬂoxacin ear
drops or systemic therapy of ciproﬂoxacin, piperacillin or ceft-
azidime can be used safely in all age groups. However injudi-
cious use of such drugs can lead to emergence of drug
resistant isolates especially in Staph. aureus and P. aerugin-
osa,27 as has previously been experienced, there should there-
fore be judicious usage of this class of antibiotics in all types
of otitis media.
The study of microbial pattern and their antibiotic sensitiv-
ity determines the prevalent bacterial organisms causing
CSOM in the local area to start empirical treatment of otitis
media and its complications for successful outcome, and thus
to prevent the emergence of resistant strains.
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